{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 cause autosomal recessive Parkinson disease (PD). The pathogenic mechanisms by which PINK1 mutations lead to neurodegeneration are unknown. PINK1 protects against oxidative-stress-induced cell death by suppressing cytochrome c release from mitochondria.",
          "judgment": "Yes",
          "reasoning": "The paper states that mutations in PINK1 are associated with Parkinson's disease, and that PINK1 protects against oxidative stress-induced cell death and cytochrome c release."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses kinase activity assays and cell survival assays to determine the impact of PINK1 variants on TRAP1 phosphorylation and cell death.",
          "judgment": "Yes",
          "reasoning": "Kinase activity and cell survival assays are relevant for assessing the function of PINK1 in preventing cell death in the context of Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "In vitro kinase assays were performed in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Data represent mean ± standard error of the mean (SEM) from three independent experiments.",
          "judgment": "Yes",
          "reasoning": "The in vitro kinase assay included a control (absence of PINK1), a wild-type control, and the data are from three independent experiments.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The paper uses wild-type PINK1 and other PD-linked mutants (W437X, L347P) as controls.",
          "judgment": "Yes",
          "reasoning": "The study includes wild-type PINK1 and other PD-linked mutants as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. Significantly different from the wild-type PINK1 (p < 0.01).",
          "judgment": "No",
          "reasoning": "The paper provides p-values but does not calculate or report OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study includes wild-type PINK1, G309D, W437X, L347P, K219A, D362A, D384A, and KDD as variants and controls.",
          "judgment": "Yes",
          "reasoning": "There are more than 11 total variants (including controls).",
          "next_step_or_outcome": "Max PS3_moderate / Max BS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The G309D variant demonstrated significantly reduced TRAP1 phosphorylation compared to wild-type PINK1. Given the use of appropriate controls and multiple replicates, this qualifies as PS3_moderate evidence."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 cause autosomal recessive Parkinson disease (PD). The pathogenic mechanisms by which PINK1 mutations lead to neurodegeneration are unknown. PINK1 protects against oxidative-stress-induced cell death by suppressing cytochrome c release from mitochondria.",
          "judgment": "Yes",
          "reasoning": "The paper states that mutations in PINK1 are associated with Parkinson's disease, and that PINK1 protects against oxidative stress-induced cell death and cytochrome c release."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses kinase activity assays and cell survival assays to determine the impact of PINK1 variants on TRAP1 phosphorylation and cell death.",
          "judgment": "Yes",
          "reasoning": "Kinase activity and cell survival assays are relevant for assessing the function of PINK1 in preventing cell death in the context of Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "In vitro kinase assays were performed in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Data represent mean ± standard error of the mean (SEM) from three independent experiments.",
          "judgment": "Yes",
          "reasoning": "The in vitro kinase assay included a control (absence of PINK1), a wild-type control, and the data are from three independent experiments.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The paper uses wild-type PINK1 and other PD-linked mutants (G309D, W437X) as controls.",
          "judgment": "Yes",
          "reasoning": "The study includes wild-type PINK1 and other PD-linked mutants as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. Significantly different from the wild-type PINK1 (p < 0.01).",
          "judgment": "No",
          "reasoning": "The paper provides p-values but does not calculate or report OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study includes wild-type PINK1, G309D, W437X, L347P, K219A, D362A, D384A, and KDD as variants and controls.",
          "judgment": "Yes",
          "reasoning": "There are more than 11 total variants (including controls).",
          "next_step_or_outcome": "Max PS3_moderate / Max BS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The L347P variant demonstrated significantly reduced TRAP1 phosphorylation compared to wild-type PINK1. Given the use of appropriate controls and multiple replicates, this qualifies as PS3_moderate evidence."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "W",
          "alt": "X",
          "position": "437"
        },
        "variant_string_id": "PINK1 W437X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 cause autosomal recessive Parkinson disease (PD). The pathogenic mechanisms by which PINK1 mutations lead to neurodegeneration are unknown. PINK1 protects against oxidative-stress-induced cell death by suppressing cytochrome c release from mitochondria.",
          "judgment": "Yes",
          "reasoning": "The paper states that mutations in PINK1 are associated with Parkinson's disease, and that PINK1 protects against oxidative stress-induced cell death and cytochrome c release."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses kinase activity assays and cell survival assays to determine the impact of PINK1 variants on TRAP1 phosphorylation and cell death.",
          "judgment": "Yes",
          "reasoning": "Kinase activity and cell survival assays are relevant for assessing the function of PINK1 in preventing cell death in the context of Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "In vitro kinase assays were performed in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Data represent mean ± standard error of the mean (SEM) from three independent experiments.",
          "judgment": "Yes",
          "reasoning": "The in vitro kinase assay included a control (absence of PINK1), a wild-type control, and the data are from three independent experiments.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The paper uses wild-type PINK1 and other PD-linked mutants (G309D, L347P) as controls.",
          "judgment": "Yes",
          "reasoning": "The study includes wild-type PINK1 and other PD-linked mutants as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. Significantly different from the wild-type PINK1 (p < 0.01).",
          "judgment": "No",
          "reasoning": "The paper provides p-values but does not calculate or report OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study includes wild-type PINK1, G309D, W437X, L347P, K219A, D362A, D384A, and KDD as variants and controls.",
          "judgment": "Yes",
          "reasoning": "There are more than 11 total variants (including controls).",
          "next_step_or_outcome": "Max PS3_moderate / Max BS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The W437X variant had a smaller but significant inhibitory effect on in vivo TRAP1 phosphorylation and cell survival, but did not have a significant effect in vitro. It qualifies as PS3_supporting evidence."
    }
  ]
}
